Stay updated on Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study page now indicates no ongoing recruitment and adds consumer guidance sections, while updating the Intervention/Treatment heading and the revision version, replacing the previous heading variant and older revision note.
    Difference
    0.5%
    Check dated 2026-06-12T16:12:29.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page footer revision label was updated from v3.5.4 to v3.5.5, indicating a site version update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-06-05T12:23:08.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page version was updated from Revision: v3.5.3 to Revision: v3.5.4, indicating a minor maintenance update. This update does not alter the study details, eligibility criteria, or other content visible to users.
    Difference
    0.1%
    Check dated 2026-05-15T05:39:33.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    The page’s displayed software/documentation revision number was incremented from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T05:47:38.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page now lists Revision: v3.5.2, replacing the previous Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:28:03.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Added 'Multiple myeloma' as a topic and introduced a new Resources section linking to the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T14:54:56.000Z thumbnail image

Stay in the know with updates to Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.